MedTrace Logo

Improving Sexually Transmitted Infection (STI) Results Notification and Partner Services

NCT01938053 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 609

Last updated 2020-09-16

No results posted yet for this study

Summary

The primary goal of this project is to improve the process for contacting patients that test positive for a sexually transmitted infection (STI) in the emergency department by using text messaging. We believe patients that are contacted by both a phone call and a text message will be reached more often and they will be reached sooner than those that only receive a phone call or only a text message. In addition, patients will be given reminder cards at the time of testing to remind them that they will be contacted within 7 days if they test positive. Half of the reminder cards will have a number to call for test results. We believe patients that receive a card with a number are more likely to be contacted within 7 days.

Conditions

  • Sexually Transmitted Infections

Interventions

OTHER

Call when test results are ready

Patients are called when the test results are ready

OTHER

Text message when test results are ready

Patients receive a text message when results are ready

OTHER

Call and text message when test results are ready

Patients receive both a call and a text message when test results are resay

Sponsors & Collaborators

  • University of Cincinnati

    collaborator OTHER

  • Children's Hospital Medical Center, Cincinnati

    lead OTHER

Principal Investigators

  • Jennifer Reed, MD · Children's Hospital Medical Center, Cincinnati

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
14 Years
Max Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-04-30
Primary Completion
2013-06-30
Completion
2013-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01938053 on ClinicalTrials.gov